🔎 Trials Near Me

Domov › Prekomerna telesna teža › Florida › Jacksonville

Klinične študije za Prekomerna telesna teža v Jacksonville, FL

19 študij za Prekomerna telesna teža išče udeležence na lokacijah v Jacksonville in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Vključevanje udeležencevFaza 2
  • Encore Research Group-Jacksonville Center for Clinical Research /ID# 282740, Jacksonville
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Vključevanje udeležencevFaza 3
  • Jacksonville Ctr Clin Res, Jacksonville
  • Northeast Research Institute, Fleming Island · 17 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Vključevanje udeležencevFaza 3
  • Jacksonville Ctr for Clin Res, Jacksonville
Starost 8–18 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07253285

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Vključevanje udeležencevFaza 2
  • Flourish Research, Jacksonville Center for Clinical Research, Jacksonville
Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Vključevanje udeležencevFaza 3
  • Jacksonville Ctr Clin Res, Jacksonville
  • Northeast Research Institute, Fleming Island · 17 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Vključevanje udeležencevFaza 3
  • Jacksonville Ctr Clin Res, Jacksonville
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07668414

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3
  • Research Site, Jacksonville
  • Research Site, Jacksonville
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07776509

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Jacksonville Center for Clinical Research, Jacksonville
  • Fleming Island Center for Clinical Research, Fleming Island · 17 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Vključevanje udeležencevFaza 3
  • Jacksonville Center for Clinical Research, Jacksonville
  • Northeast Research Institute (NERI), Fleming Island · 17 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Research Site, Fleming Island · 17 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Vključevanje udeležencevFaza 3
  • East Coast Institute for Research, LLC, Jacksonville
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Westside Center for Clinical Research, Jacksonville
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07353931

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Vključevanje udeležencevFaza 3
  • AURORA-1 Clinical Site, Jacksonville
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • AURORA-2 Clinical Site, Jacksonville
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
  • ACCOMPLISH-2 Research Site, Jacksonville
Starost 18–79 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07654374

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Vključevanje udeležencevFaza 3
  • Jacksonville Center for Clinical Research, Jacksonville
  • Clinical Neuroscience Solutions - Jacksonville, Jacksonville
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684235

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3
  • Research Site, Jacksonville
Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07784725

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Vključevanje udeležencevFaza 3
  • Westside Center For Clinical Research, Jacksonville
  • Clinical Neuroscience Solutions, LLC, Jacksonville
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT07509307

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Vključevanje udeležencevFaza 1
  • Jacksonville Ctr For Clin Res, Jacksonville
  • Northeast Research Institute, Fleming Island · 17 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. jun. 2026 · NCT07607587

Študije za Prekomerna telesna teža v drugih mestih

Druge študije v Jacksonville

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.